European private equity house Montagu has entered exclusive negotiations with Bridgepoint to acquire HTL Biotechnology, a fast-growing biotech and industrial business specialising in pharmaceutical grade biopolymers.
The post Bridgepoint sells fast-growing biotech business HTL to Montagu first appeared on AltAssets Private Equity News.
